A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

August 31, 2007

Conditions
Multiple Sclerosis
Trial Locations (28)

10601

Family Health Center, White Plains

15213

University of Pittsburgh, Pittsburgh

22031

Neurology Center of Fairfax, Ltd., Fairfax

33609

Tampa Neurology, Tampa

35058

Physicians Resource Network, Cullman

35294

University of Alabama - Birmingham, Birmingham

37205

The Advanced Neurosciences Institute, Nashville

37212

Vanderbilt University, Nashville

37922

The Baptist Hospital of East Tennessee, Knoxville

40202

Kentucky Neuroscience Research / University Neurologists, P.S.C, Louisville

43221

The Multiple Sclerosis Center at the Ohio State University, Columbus

46805

Fort Wayne Neurological Center, Fort Wayne

48109

University of Michigan, Ann Arbor

50314

Mercy Ruan Neurology Clinic, Des Moines

60611

Northwestern University, Chicago

60637

University of Chicago, Chicago

61637

OSF Saint Francis Medical Center, Illinois Neurological Institute, Peoria

63110

BJC Medical Group, St Louis

Washington University, St Louis

71130

Louisiana State University Health Sciences Center, Shreveport

77030

Baylor College of Medicine - The Methodist College Multiple Sclerosis Center, Houston

The University of Texas Houston, Houston

85013

Barrow Neurological Institute, Phoenix

92697

University of California - Irvine, Irvine

94117

University of California San Francisco - MS Center, San Francisco

95405

Neurology Associates of Tacoma, Tacoma

98195

University of Washington, Seattle

02905

Brown University / Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY